Background-Increasing sarcoplasmic/endoplasmic reticulum (SR) Ca 2ϩ -ATPase (SERCA) uptake activity is a promising therapeutic approach for heart failure. We investigated the effects of different levels of SERCA1a expression on contractility and Ca 2ϩ cycling. We tested whether increased SERCA1a expression levels enhance myocyte contractility in a gene-dose-dependent manner. Methods and Results-Rabbit isolated cardiomyocytes were transfected at different multiplicities of infection (MOIs) with adenoviruses encoding SERCA1a (or ␤-galactosidase as control). Myocyte relaxation half-time was decreased by 10% (Pϭ0.052) at SERCA1a MOI 10 and by 28% at MOI 50 (PϽ0.05). Myocyte fractional shortening was increased by 12% at MOI 10 (PϽ0.05) but surprisingly decreased at MOI 50 (Ϫ22%, PϽ0.05) versus control. SR Ca 2ϩ uptake (in permeabilized myocytes) demonstrated a gene-dose-dependent decrease in K m by 29% and 46% and an increase in V max by 37% and 72% at MOI 10 and MOI 50, respectively (all PϽ0.05 versus control). Ca 2ϩ transient amplitude was increased in Ad-SERCA1a-infected myocytes at MOI 10 (by 121%, PϽ0.05), but at MOI 50, the Ca 2ϩ transient amplitude was not significantly changed. Caffeine-induced Ca 2ϩ transients indicated significantly increased SR Ca 2ϩ content in Ad-SERCA1a-infected cells, by 72% at MOI 10 and by 87% at MOI 50. Mathematical simulations demonstrate that the functional increase in SR Ca 2ϩ -ATPase uptake activity at MOI 50 (and increased cytosolic Ca 2ϩ buffering) is sufficient to curtail the Ca 2ϩ transient amplitude and explain the reduced contraction. Conclusions-Moderate SERCA1a gene transfer and expression improve contractility and Ca 2ϩ cycling. However, higher SERCA1a expression levels can impair myocyte shortening because of higher SERCA activity and Ca 2ϩ buffering. (Circulation. 2004;110:3553-3559.)
C hanges in myocardial excitation-contraction coupling are important in the pathophysiology of heart failure. Increased expression of Na ϩ -Ca 2ϩ exchanger (NCX), altered ryanodine receptor (RyR) function, and decreased expression of SR Ca 2ϩ -ATPase (SERCA) contribute to reduced SR Ca 2ϩ accumulation. Furthermore, an increased phospholamban (PLB)/SERCA2a ratio reduces SERCA activity. 1 Decreased SR Ca 2ϩ uptake activity slows relaxation and depresses contractility (because of reduced SR Ca 2ϩ loading). In mice, disruption of 1 copy of the SERCA2 gene reduced the maximum velocity of SR Ca 2ϩ uptake in homogenates, SR Ca 2ϩ content and contractility in isolated cardiomyocytes, and in vivo cardiac performance. 2, 3 Thus, restoring SR Ca 2ϩ uptake may be valuable therapeutically in heart failure. Accordingly, transgenic mice overexpressing SERCA2a exhibited improved cardiac function and Ca 2ϩ handling. 4, 5 In neonatal rat cardiomyocytes with normal and depressed SERCA2a expression, adenovirus-mediated overexpression of SERCA2a resulted in enhanced SR Ca 2ϩ uptake and accelerated decay of Ca 2ϩ transients. 6, 7 Furthermore, catheter-based transfection with an adenovirus encoding SERCA2a restored cardiac function in rats in transition to heart failure 8 and improved survival. 9 In human cardiomyocytes isolated from end-stage failing hearts, adenovirusmediated augmented expression of SERCA2a resulted in enhanced contractility and Ca 2ϩ handling. 10 Here, we tested the hypothesis that increasing levels of SERCA expression progressively enhance contractility and relaxation rate. We used adenovirus-mediated gene transfer of SERCA1a into isolated rabbit ventricular cardiomyocytes. SERCA1a is a splice transcript of the SERCA1 gene (expressed in adult fast-twitch skeletal muscle) that has faster Ca 2ϩ transport kinetics 11 and might achieve higher levels of SERCA activity than equivalent upregulation of SERCA2a. 12 Rabbit ventricular myocytes were used because excitationcontraction coupling in rabbit myocardium is similar to that in humans. 13, 14 
Methods

Primary Culture of Rabbit Ventricular Myocytes and Adenovirus Transfection
Ventricular cardiomyocytes were isolated from adult female Chinchilla Bastard rabbits (2.0 to 2.5 kg) as previously described. 15 Myocytes were counted, and adenoviral transfection was performed at the indicated multiplicity of infection (MOI) while the cells were plated on laminin-coated 35-mm dishes at a density of 5ϫ10 5 rod-shaped myocytes/dish. This study was designed and performed in accordance with institutional guidelines for the care and use of animals.
Recombinant Adenovirus
Adenovirus containing the SERCA1a gene (Ad-SERCA1a) was generated as described previously. 16 Briefly, cDNA of the chicken SERCA1a gene was expressed as a fusion protein with a c-terminal c-myc tag under control of the constitutively active cytomegalovirus promoter.
Verification of Transgene Expression and Expression Pattern
Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed after 48 hours of culture. Specific primers for chicken SERCA1a and rabbit calsequestrin were used for amplification. For Western immunoblot, a polyclonal anti-c-myc antibody (PA1-981, ABR) was used at a dilution of 1:5000 to detect the expressed protein.
Single Myocyte Shortening and Intracellular Ca 2؉ Measurements
The stimulation frequency was 1 Hz, and myocytes were continuously perfused with Krebs buffer (2 mmol/L CaCl 2 at 36°C to 37°C). In separate experiments, intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) was measured with Fura-2 (-AM loaded) was used as previously outlined. 17 After 60 to 90 seconds of continuous 1-Hz stimulation, SR Ca 2ϩ content was estimated by the transient rise in [Ca 2ϩ ] i induced by rapid application of 10 mmol/L caffeine for 3 to 5 seconds. 18
Measurements of SR Ca 2؉ Uptake Characteristics
Myocytes (Ϸ5ϫ10 5 /mL, 48 hours after transfection) were permeabilized using 0.1 mg/mL ␤-escin. Myocyte suspensions (Ϸ4ϫ10 5 cells/mL) were stirred, and Fura-2 (10 mol/L, Molecular Probes) was used to monitor [Ca 2ϩ ] (20°C to 22°C). Oxalate (10 mmol/L) was included to maintain low and constant intra-SR [Ca 2ϩ ] and ruthenium red (2.7 mol/L) to block SR Ca 2ϩ efflux.
Mathematical Modeling and Analysis
Simulations were based on mean measured Ca 2ϩ transient parameters (see Table 2 ). Equations were derived to describe the intrinsic [Ca 2ϩ ] i dependence of Ca 2ϩ transport by the SR Ca 2ϩ pump (J SR-Pump ) and NCX (J NCX ), reported in mol/L cytosol per second (or simply mol/L/s). 19 Ca 2ϩ transients were simulated using these fluxes plus fluxes for SR Ca 2ϩ release (J Rel ) and Ca 2ϩ current (I Ca ) as required to produce the measured Ca 2ϩ transient characteristics.
Statistics
Data are presented as meanϮSEM based on the number of animals (ie, number of transfections) to allow the comparison of the Ca 2ϩ uptake characteristics from cell aggregates. The number of cells was used to compare contractility and [Ca 2ϩ ] i measurements; the number of animals (ie, transfections) is also reported. Statistical analysis used paired Student t test or Wilcoxon signed-rank test as appropriate. A value of PϽ0.05 was considered significant.
Details of all aspects of the techniques used in this study are given in the online-only Data Supplement.
Results
Efficiency of Transgene Expression
Transgene expression of SERCA1a was confirmed by use of RT-PCR and Western blot immunodetection. Both methods demonstrated a dose-dependent increase in transgene expression ( Figure 1 ) without changes in calsequestrin levels, which served as an internal standard. Immunohistochemical studies demonstrated a similar striated pattern of expression in both the MOI 10 and MOI 50 Ad-SERCA1a groups (see onlineonly Data Supplement), suggesting that there were no differences in the trafficking of SERCA1a at these 2 MOI values.
Contractile Parameters
Single-cell shortening was measured 48 hours after transfection ( Figure 2 , Table 1 ). At MOI 10, time to peak cell shortening (TTP) was reduced by 10%, relaxation time (RT 50 ) was reduced by 11%, and fractional shortening was 12% higher in Ad-SERCA1a-infected myocytes versus control ( Figure 2 , Table 1 ). Increasing Ad-SERCA1a to MOI 50 caused further abbreviation of time to peak shortening (by 23%) and RT 50 (by 28%), but fractional shortening was decreased by 22% at the higher level of SERCA1a expression compared with control ( Figure 2 , Table 1 ). The difference in shortening observed in the Ad-LacZ groups (MOI 10 versus MOI 50) is not a result of the different MOIs (not shown) but is likely to be a result of variation in isolated myocytes batches, in which MOI 10 studies (ϮSERCA1a) were performed in 1 set of cells and the MOI 50 studies were performed with separate batches of cells on different days. To exclude the influence of isolation and culture, mean values for each experimental day (for LacZ and SERCA) were compared using a paired t test (Table 1) . Ca 2ϩ transient measurements were made separately, and both MOI values were studied at the same time. Table 2 , the Ca 2ϩ transient amplitude in cells infected with Ad-SERCA1a at MOI 10 was increased significantly, by 121%, versus control (Ad-LacZ), whereas the 18% increase in Ca 2ϩ transient amplitude at MOI 50 was not significant (versus control). At MOI 10, diastolic [Ca 2ϩ ] i was not significantly different, but peak [Ca 2ϩ ] i was increased by 75%. At MOI 50, diastolic [Ca 2ϩ ] i was decreased significantly, by 32%, but peak [Ca 2ϩ ] i was not significantly different from that with Ad-LacZ-50. At both MOIs, the rate constant of the decline of [Ca 2ϩ ] i was increased in the Ad-SERCA1a group compared with the control cells ( Table  2 ). As illustrated in Figures 3 and 4 , SR Ca 2ϩ content (assessed by rapid caffeine application) after 1-Hz stimulation was 72% higher in Ad-SERCA1a (MOI 10) than in control Ad-LacZ-10 myocytes. At MOI 50, caffeine-induced Ca 2ϩ transient was 87% higher compared with the Ad-LacZ control group (Figure 4 , Table 2 ). Thus, there is a SERCA1a gene-dose-dependent increase in the rate of diastolic [Ca 2ϩ ] i decline, consistent with increased SR Ca 2ϩ -ATPase function, but Ca 2ϩ transient amplitude did not increase at the higher gene dose, and contraction decreased.
Stimulated and Caffeine-Induced Ca 2؉ Transients
As shown in Figures 3 and 4 and
SR Ca 2؉ Uptake Rates
As shown in Figure 5 , oxalate-supported Ca 2ϩ uptake was measured in permeabilized cardiomyocytes after transfection with Ad-LacZ and Ad-SERCA1a. The decay of the [Ca 2ϩ ] in the cuvette after addition of an aliquot of CaCl 2 (50 nmol) was faster after Ad-SERCA1a transfection compared with the Ad-LacZ control, indicating increased Ca 2ϩ uptake rate (Figure 5C) . A quantitative description of SERCA activity was obtained by calculating the changes of total [Ca 2ϩ ] on the basis of the known Ca 2ϩ buffering capacity of the extracellular solution ( Figure 5A ). Differentiation of the total [Ca 2ϩ ] signal reveals the rate of Ca 2ϩ uptake that can be plotted against the associated free [Ca 2ϩ ] to obtain a sigmoidal relationship ( Figure 5B ). This relationship was fitted with a logistic curve to estimate the free [Ca 2ϩ ] that generated half the maximal Ca 2ϩ uptake rate (K m ) and the value of the maximal rate of Ca 2ϩ uptake (V max ). Table 2 shows mean values of V max and K m for Ad-LacZ and Ad-SERCA1a transfection at the 2 MOIs used. Cells infected with Ad-LacZ (MOI 10 versus MOI 50) exhibited comparable Ca 2ϩ affinity (K m ) and V max . Transfection with Ad-SERCA1a decreased the K m of SERCA-mediated SR Ca 2ϩ uptake by 29% and 46% (at MOI 10 and MOI 50, respectively, versus controls). The V max increased by 37% and 71% at MOI 10 and MOI 50, respectively (versus controls). This is consistent with a gene-dose-dependent increase in SR Ca 2ϩ -ATPase function.
Intact Myocyte Ca 2؉ Flux Analysis
Simulations were used to clarify the lack of Ca 2ϩ transient enhancement at high SERCA1a MOI. Figure 6A shows the [Ca 2ϩ ] i dependence of Ca 2ϩ transport by the SERCA and NCX inferred from stimulated and caffeine-induced Ca 2ϩ transients in intact myocytes. All 4 J NCX curves were almost Table 2) identical, so only the mean curve is shown. The V max for J SR-Pump was increased from 100 to 167 mol/L/s in Ad-SERCA1a versus Ad-LacZ at MOI 10 and from 125 to 275 mol/L/s for Ad-SERCA1a versus Ad-LacZ at MOI 50, respectively (ie, 60% and 85% increases in V max ). The apparent Ca 2ϩ affinity was only slightly enhanced in the Ad-SERCA1a MOI 10 (K m ϭ197 versus 210 nmol/L), but the shift was greater in Ad-SERCA1a MOI 50 (164 versus 183 nmol/L). These results are consistent with the increases measured in permeabilized cells (although absolute values differ). Figure 6B shows simulated Ca 2ϩ transients for Ad-LacZ (MOI 10) and Ad-SERCA1a (MOI 10). For the SERCA-10 transient, the appropriate J SR-Pump (and J NCX ) characteristics were used, and the SR Ca 2ϩ release flux (J Rel peakϭ3 mmol/ L/s, integralϭ49 mol/L) had to be scaled up by 97%. This exceeds the 72% increase in SR Ca 2ϩ content assessed by caffeine, consistent with an increased fractional SR Ca 2ϩ release at higher SR Ca 2ϩ load. 19 The broken curve in Figure  6B shows what would happen if we had increased only J Rel without increasing SR Ca 2ϩ -ATPase activity. This suggests that the enhanced J SR-Pump limits the rise in Ca 2ϩ -transient amplitude by only Ϸ13%. Figure 6C shows similar curves for the SERCA-50 case. The lower 2 curves reflect measured results. The broken curves simulate transients with the same increase in J Rel but without increasing SR Ca 2ϩ pump function (shown), without increasing buffering (not shown), or both (top curve). Under those conditions, the Ca 2ϩ transient would be larger. That is, Ca 2ϩ transient amplitude for a given J Rel is curtailed by 47% by the increased Ca 2ϩ -pump rate, 33% by the higher buffering, and 75% when combined. This analysis indicates that increasing SR Ca 2ϩ pumps above an optimal value may buffer and curtail the Ca 2ϩ transient without further raising SR Ca 2ϩ load.
Discussion
The present study demonstrates that dissociation between SR Ca 2ϩ content and myocyte fractional shortening occurs at high levels of SERCA1a overexpression. At MOI 10, myocytes expressing SERCA1a (versus Ad-LacZ controls) revealed enhanced SR Ca 2ϩ uptake, relaxation rates, SR Ca 2ϩ content, isotonic shortening, and Ca 2ϩ transient amplitude. At higher SERCA expression levels (at MOI 50), myocytes exhibited further increases in SR Ca 2ϩ uptake, relaxation rate, and SR Ca 2ϩ content but showed depressed contraction amplitude and no Ca 2ϩ transient enhancement versus control. We infer that high SERCA activity causes a paradoxical decreased contractile activation because of greater Ca 2ϩ removal from the cytosol.
Several studies have shown that increased SR Ca 2ϩ -ATPase expression improves Ca 2ϩ cycling and myocardial function. Here, the fast-twitch skeletal muscle SERCA1a was used because it has faster Ca 2ϩ transport kinetics versus SERCA2a. 11, 16 Furthermore, SERCA1a transfection in cultured neonatal cardiomyocytes generated higher SERCA protein levels than parallel SERCA2a studies. 12 SERCA1a targets to intracellular membranes after adenovirus-mediated gene transfer into embryonic cardiac myocytes in a pattern identical to that of SERCA2a. 20 Confocal studies on transgenic mice expressing SERCA1a in the heart showed traffic of SERCA1a to cardiac SR. 21 A similar expression pattern was found in the present study.
In both our ␤-escin-permeabilized and intact cells, SR Ca 2ϩ uptake demonstrated a gene-dose-dependent increase in V max and Ca 2ϩ affinity (reduced K m ) in SERCA1a-expressing cells ( Figures 5C and 6A and Table 2 ). Although SERCA1a and SERCA2a have identical Ca 2ϩ concentration dependence 11 and are both regulated by PLB, 22, 23 the shift in K m in SERCA1 cells may indicate an increased SERCA/PLB ratio, with more Ca 2ϩ pumps unregulated by PLB.
At MOI 10, improved SR Ca 2ϩ uptake was accompanied by larger Ca 2ϩ transients, contractions, SR Ca 2ϩ content, and rates of [Ca 2ϩ ] i decline and relaxation. These findings are Broken curve demonstrates expected intracellular Ca 2ϩ transients as a consequence of increased SR-Ca 2ϩ content and therefore increased SR Ca 2ϩ release (J Rel ) but without increased SERCA activity. C, Similar curves at MOI 50. Solid curves represent measured results. Broken curves are with higher SERCA-50 J Rel but without increasing J SR-Pump activity (long dash) and without increasing J SR-Pump and without increased cytosolic Ca 2ϩ buffering associated with additional SR Ca 2ϩ pumps (short dash). consistent with previous studies with SERCA1a transfection in chicken or rat cardiomyocytes. 12, 20, 21 Interestingly, higher virus titer (MOI 50) and SERCA1a protein expression decreased twitch contraction amplitude and failed to enhance Ca 2ϩ transient amplitude, despite enhanced SERCA activity, SR Ca 2ϩ load, twitch [Ca 2ϩ ] i decline, and relaxation rates. This indicates that above an optimum SERCA1a expression level (for Ca 2ϩ transient amplitude), greater SERCA1a expression may limit Ca 2ϩ transient amplitude. The higher rate of [Ca 2ϩ ] i decline after SERCA1a overexpression is paralleled by the increase in caffeine-releasable Ca 2ϩ . This strongly suggests that the additional efflux of Ca 2ϩ from the cytosol is directed into the SR and not the sarcolemma. The unaltered NCX function (based on rate constants of [Ca 2ϩ ] i in the presence of caffeine) indicates that there were no compensatory changes in NCX transport during these studies. Thus, the net effect of high levels of SERCA1a overexpression is to enhance relaxation and, by shortening of the duration of activation of the contractile proteins, to reduce the amplitude of myocyte shortening.
On the basis of the rate constants of [Ca 2ϩ ] i decline, 19 the contribution of NCX to [Ca 2ϩ ] i decline was 25% to 26% in Ad-LacZ-infected myocytes, as in previous data in rabbit. 13 However, with enhanced SERCA1a expression (MOI 10 and MOI 50), NCX contribution decreased to 20% and 13%, respectively. This is consistent with the stronger competition of SERCA versus NCX. The Ca 2ϩ flux analysis and simulations help to explain the unaltered Ca 2ϩ transient amplitude and decreased isotonic shortening despite increased SR Ca 2ϩ load and pump function at high SERCA overexpression. Greater SR Ca 2ϩ pump expression can limit the Ca 2ϩ transient by curtailing the peak. The impact of this effect is shown in Figure 6 , B and C. Analogous data in rabbit myocytes showed that acute SERCA block with thapsigargin (without unloading the SR) increased Ca 2ϩ transient amplitude by Ϸ20%. 13 A second means by which increased SERCA expression can limit [Ca 2ϩ ] i is that it adds to cytosolic Ca 2ϩ buffering. After troponin C (Ϸ70 mol/L), the SR Ca 2ϩ pump is the most prominent cytosolic Ca 2ϩ buffer (Ϸ50 mol/L), with equally high affinity. 19 Thus, a 50% increase in SR Ca 2ϩ pump expression would compete for Ca 2ϩ binding to troponin C and limit the amplitude of the Ca 2ϩ transient (see Figure 6C ). The lower diastolic [Ca 2ϩ ] in SERCA-overexpressing cells will also contribute to the absence of improved inotropy, because a larger SR Ca 2ϩ release would be required to achieve peak systolic [Ca 2ϩ ] levels that were comparable to control. Third, more SR Ca 2ϩ pumps can increase the rate of SR Ca 2ϩ uptake but may not increase maximal SR Ca 2ϩ load for a given [Ca 2ϩ ] i . 24 -26 This is because the SR Ca 2ϩ -ATPase can only build a [Ca 2ϩ ] gradient (or potential energy) related to ⌬G ATP (eg, ⌬G SR-Pump ϭ2 RT ln ([Ca 2ϩ ] SR /[Ca 2ϩ ] i ) or [Ca 2ϩ ] SR /[Ca 2ϩ ] i Ϸ7000). 25 Thus, higher SR Ca 2ϩ pump expression may allow a closer approach toward this limit (and get there faster), but there is a limit. It is notable that the diastolic [Ca 2ϩ ] i was significantly lower and SR Ca 2ϩ load significantly higher in SERCA-50 versus LacZ-50, and this may represent an approach to this limiting [Ca 2ϩ ] SR /[Ca 2ϩ ] i gradient. Thus, at high SERCA levels, one may approach a maximal SR Ca 2ϩ load that more SERCA cannot further improve.
Very high levels of SERCA1a gene transfer into neonatal rat and embryonic chicken cardiomyocytes could also produce cytotoxic effects, possibly related to SR dysfunction. 27 This did not occur here, where we saw enhanced SR Ca 2ϩ transport and load and reduced diastolic [Ca 2ϩ ] i at the highest SERCA1a expression levels.
In conclusion, the dose of SERCA1a overexpression is critical for improved myocardial function. Although increased SR Ca 2ϩ pump expression can enhance SR Ca 2ϩ content, Ca 2ϩ transient amplitude, and diastolic function, there may be an optimum value above which limiting factors prevent further increase in Ca 2ϩ transients and can even reduce myocyte shortening. Although we used chicken SERCA1a and rabbit myocytes, we believe that the present findings are transferable to other species and SERCA isoforms. Increasing SR Ca 2ϩ pump function in failing hearts (with low functional SERCA2a expression) may be beneficial, but the same SERCA1a expression in myocardium with normal SERCA2a levels could be detrimental. We conclude that the use of SERCA1a for gene therapy in heart failure requires careful control of transfection efficiency and induced expression levels.
